Pantoprazole Sodium Granule, Delayed Release
Product Images NDC 59651-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 59651-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Pantoprazole Fig1)

Label for PANTOPRAZOLE SODIUM 40 mg delayed-release granule oral suspension, a prescription drug by Aurobindo Pharma Limited. The label includes directions for opening the package and emphasizes that the product is for oral suspension use.*

FDA Label Image

Fig2 (Pantoprazole Fig2)

Packaging label for Pantoprazole Sodium 40 mg delayed-release oral suspension granules by Aurobindo Pharma Limited. The carton states it contains 30 packets and notes the suspension should be mixed with apple juice or applesauce only. The label includes pharmacist instructions to dispense the Medication Guide separately, storage and administration directions, a barcode, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Str (Pantoprazole Str)

Chemical structure of pantoprazole sodium, showing its molecular connectivity including sulfur, nitrogen, and oxygen atoms, along with sodium ion and associated water molecules (1.5 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.